Preetam Shah - Mar 31, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CFO & CBO
Signature: /s/ Preetam Shah
Stock symbol: CDTX
Transactions as of: Mar 31, 2022
Transactions value $: -$20,601
Form type: 4
Date filed: 4/4/2022, 05:21 PM
Previous filing: Nov 15, 2021
Next filing: Sep 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+51.3K	+256.25%	$0.00	71.3K	Mar 31, 2022	Direct	F1
transaction	CDTX	Common Stock	Award	$0	+66K	+92.63%	$0.00	137K	Mar 31, 2022	Direct	F2
transaction	CDTX	Common Stock	Tax liability	-$20.6K	-24.8K	-18.08%	$0.83	112K	Mar 31, 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+103K		$0.00	103K	Mar 31, 2022	Common Stock	103K	$0.83	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date.
F3	Shares withheld for taxes on RSU vesting.
F4	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.